Post by
MartialArts on Mar 08, 2018 1:18pm
GT, are you accusing Canaccord of manipulating the stock?
GT, you write "I don’t see CMED shares going past $43 and most likely hover around current price $38-$40 range to save ACB paying more cash. Cannacord, the ACB financial backers will make sure that doesn’t happen."
Do you have any proof that Canaccord is manipulating the stock?
Also if they could wouldn't they drive up the stock above $43 to have people select the all-share option saving the $140M?